These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3117361)

  • 1. Glucocorticoid sensitivity of OVCA 433 human ovarian carcinoma cells: inhibition of plasminogen activators, cell growth, and morphological alterations.
    Amin W; Karlan BY; Littlefield BA
    Cancer Res; 1987 Nov; 47(22):6040-5. PubMed ID: 3117361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal regulation of CA125 tumor marker expression in human ovarian carcinoma cells: inhibition by glucocorticoids.
    Karlan BY; Amin W; Casper SE; Littlefield BA
    Cancer Res; 1988 Jun; 48(12):3502-6. PubMed ID: 3285997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mechanisms contribute to simultaneous inhibition of urokinase and tissue-type plasminogen activators by glucocorticoids in human ovarian carcinoma cells.
    Karlan BY; Rivero JA; Crabtree ME; Littlefield BA
    Mol Endocrinol; 1989 Jun; 3(6):1006-13. PubMed ID: 2500590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells.
    Band V; Karlan BY; Zurawski VR; Littlefield BA
    J Cell Physiol; 1989 Jan; 138(1):106-14. PubMed ID: 2492025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts.
    Littlefield BA; Johnston LJ; Manzer DS; Roche PC
    Endocrinology; 1985 Sep; 117(3):1100-9. PubMed ID: 3926465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA.
    Gomi M; Moriwaki K; Katagiri S; Kurata Y; Thompson EB
    Cancer Res; 1990 Mar; 50(6):1873-8. PubMed ID: 2106390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated glucocorticoid receptor binding in cultured human lymphoblasts following hydroxyurea treatment: lack of effect on steroid responsiveness.
    Littlefield BA; Hoagland HC; Greipp PR
    Cancer Res; 1986 Aug; 46(8):3945-50. PubMed ID: 3731065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucocorticoid on proliferation, differentiation, and glucocorticoid receptor expression in human ovarian carcinoma cell line 3AO.
    Xu MJ; Fang GE; Liu YJ; Song LN
    Acta Pharmacol Sin; 2002 Sep; 23(9):819-23. PubMed ID: 12230951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine synthetase induction by glucocorticoids in the glucocorticoid-sensitive human leukemic cell line CEM-C7.
    Harmon JM; Thompson EB
    J Cell Physiol; 1982 Feb; 110(2):155-60. PubMed ID: 6121820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinoic acid and dexamethasone on proliferation, differentiation, and glucocorticoid receptor expression in cultured human osteosarcoma cells.
    Song LN
    Oncol Res; 1994; 6(3):111-8. PubMed ID: 7994082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Dexamethasone on glucocorticoid receptor expression in a human ovarian carcinoma cell line 3AO.
    Xu M; Song L; Wang Z
    Chin Med J (Engl); 2003 Mar; 116(3):392-5. PubMed ID: 12781044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F; Wilson EL; Mignatti P; Rifkin DB
    J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional glucocorticoid receptor modulates pancreatic carcinoma growth through an autocrine loop.
    Norman J; Franz M; Schiro R; Nicosia S; Docs J; Fabri PJ; Gower WR
    J Surg Res; 1994 Jul; 57(1):33-8. PubMed ID: 7518883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
    Rosanò L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
    Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.
    Harvey SR; Nayak SK; Markus G; Ouhammouch M; Hemperly JJ; Dillman RO; Doyle DJ
    Arch Biochem Biophys; 1997 Sep; 345(2):289-98. PubMed ID: 9308901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines.
    Jones J; Lagasse LD; Karlan BY
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):421-6. PubMed ID: 7835782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid sensitivity and receptors in cells of human myelogenous leukemia lines.
    Koeffler HP; Golde DW; Lippman ME
    Cancer Res; 1980 Mar; 40(3):563-6. PubMed ID: 6937238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced growth inhibition and differentiation of a human megakaryoblastic leukemia cell line: involvement of glucocorticoid receptor.
    Song LN; Cheng T
    Stem Cells; 1993 Jul; 11(4):312-8. PubMed ID: 8401254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator and serine protease inhibitor-E2 (protease nexin-1) expression by bovine granulosa cells in vitro.
    Cao M; Sahmi M; Lussier JG; Price CA
    Biol Reprod; 2004 Sep; 71(3):887-93. PubMed ID: 15128599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.